Bank of America – Bank of America Raises Allscripts Healthcare Options (NASDAQ:MDRX) price Target to $16.50

Allscripts Healthcare Options (NASDAQ:MDRX) had its goal price upped by Bank of America from $14.00 to $16.50 in a analysis report issued to shoppers and buyers on Wednesday, Fintech Zoom studies. The agency presently has a “purchase” score on the software program maker’s stock. Bank of America‘s goal price points to a possible upside of 15.95% from the stock’s present price.

Different analysts have additionally issued studies concerning the firm. Cantor Fitzgerald raised their price goal on Allscripts Healthcare Options from $9.00 to $13.00 and gave the corporate a “impartial” score in a report on Wednesday, October 14th. ValuEngine lowered shares of Allscripts Healthcare Options from a “maintain” score to a “promote” score in a report on Monday, October 12th. Robert W. Baird reduce shares of Allscripts Healthcare Options from an “outperform” score to a “impartial” score and set a $13.00 price goal for the corporate. in a analysis report on Monday, October 19th. BidaskClub lowered shares of Allscripts Healthcare Options from a “maintain” score to a “promote” score in a analysis report on Saturday, September 19th. Lastly, JPMorgan Chase & Co. downgraded shares of Allscripts Healthcare Options from a “impartial” score to an “underweight” score and upped their price goal for the stock from $9.00 to $11.00 in a analysis report on Friday, October 23rd. Six equities analysis analysts have rated the stock with a promote score, seven have given a maintain score and 6 have issued a purchase score to the corporate’s stock. The stock presently has a consensus score of “Maintain” and a mean price goal of $10.47.

Shares of MDRX traded up $0.03 throughout buying and selling hours on Wednesday, hitting $14.23. The stock had a buying and selling quantity of 75,159 shares, in comparison with its common quantity of two,117,994. The agency has a 50-day transferring common price of $10.85 and a 200 day transferring common price of $8.40. Allscripts Healthcare Options has a fifty-two week low of $4.56 and a fifty-two week excessive of $14.37. The agency has a market capitalization of $2.24 billion, a price-to-earnings ratio of -47.30, a PEG ratio of three.05 and a beta of 0.94. The corporate has a debt-to-equity ratio of 0.85, a fast ratio of 0.78 and a present ratio of 1.27.

Allscripts Healthcare Options (NASDAQ:MDRX) final issued its quarterly earnings knowledge on Tuesday, November third. The software program maker reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.01. Allscripts Healthcare Options had a adverse web margin of two.77% and a constructive return on fairness of 5.80%. The enterprise had income of $402.00 million through the quarter, in comparison with the consensus estimate of $419.75 million. Throughout the identical quarter within the prior yr, the agency posted $0.17 earnings per share. The corporate’s income was down 9.7% in comparison with the identical quarter final yr. As a bunch, analysts predict that Allscripts Healthcare Options will publish 0.49 EPS for the present fiscal yr.

In different information, CEO Paul Black bought 30,000 shares of the corporate’s stock in a transaction that occurred on Wednesday, October 14th. The shares have been bought at a mean price of $11.04, for a complete value of $331,200.00. The sale was disclosed in a doc filed with the SEC, which is obtainable by way of this hyperlink. Additionally, insider Lisa Khorey bought 15,000 shares of the stock in a transaction that occurred on Wednesday, October 14th. The stock was bought at a mean price of $11.04, for a complete transaction of $165,600.00. Following the transaction, the insider now immediately owns 270,889 shares of the corporate’s stock, valued at roughly $2,990,614.56. The disclosure for this sale may be discovered right here. Within the final ninety days, insiders bought 60,000 shares of firm stock worth $688,050. Company insiders personal 1.42% of the corporate’s stock.

Massive buyers have just lately added to or lowered their stakes within the enterprise. New Mexico Academic Retirement Board acquired a brand new stake in Allscripts Healthcare Options through the third quarter worth roughly $325,000. State of Tennessee Treasury Division acquired a brand new stake in shares of Allscripts Healthcare Options within the second quarter valued at $380,000. Bank of Montreal Can raised its stake in shares of Allscripts Healthcare Options by 380.8% within the second quarter. Bank of Montreal Can now owns 20,108 shares of the software program maker’s stock valued at $129,000 after buying an extra 15,926 shares within the final quarter. Bank of America Corp DE boosted its holdings in Allscripts Healthcare Options by 10.4% within the second quarter. Bank of America Corp DE now owns 1,522,907 shares of the software program maker’s stock valued at $10,310,000 after buying an extra 143,593 shares through the interval. Lastly, Envestnet Asset Administration Inc. acquired a brand new place in Allscripts Healthcare Options through the 2nd quarter worth $73,000.

Allscripts Healthcare Options Firm Profile

Allscripts Healthcare Options, Inc offers info know-how options and providers to healthcare organizations in the US, Canada, and internationally. It affords digital well being information (EHR), info connectivity, personal cloud internet hosting, outsourcing, analytics, affected person entry, and inhabitants well being administration options.

Beneficial Story: Limitations of the P/E Development ratio

This on the spot information alert was generated by narrative science know-how and monetary knowledge from MarketBeat so as to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial staff previous to publication. Please ship any questions or feedback about this story to [email protected]